Third Wave's Q3 Revenues Jump 26 Percent as Net Loss Declines 30 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Third Wave Technologies today said third-quarter revenues increases 26 percent as net loss declined 30 percent.
 
Total receipts for the three months ended Sept. 30 increased to $6.6 million from $5.2 million year over year. Molecular diagnosis contributed $5.2 million.
 
R&D expenses on the quarter were up sharply, at $3.5 million compared with $2 million the previous year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.